ES2549189B2 - Composición para el tratamiento de la alopecia masculina - Google Patents
Composición para el tratamiento de la alopecia masculina Download PDFInfo
- Publication number
- ES2549189B2 ES2549189B2 ES201430596A ES201430596A ES2549189B2 ES 2549189 B2 ES2549189 B2 ES 2549189B2 ES 201430596 A ES201430596 A ES 201430596A ES 201430596 A ES201430596 A ES 201430596A ES 2549189 B2 ES2549189 B2 ES 2549189B2
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- composition
- male alopecia
- alopecia
- male
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 201000004384 Alopecia Diseases 0.000 title abstract 3
- 231100000360 alopecia Toxicity 0.000 title abstract 3
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 abstract 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 abstract 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013619 trace mineral Nutrition 0.000 abstract 1
- 239000011573 trace mineral Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composición para el tratamiento de la alopecia masculina. Se describe una composición que se administra por vía oral para el tratamiento de la alopecia masculina. Las composiciones comprenden aminoácidos, oligoelementos, metilsulfona, colina, cistina y un inhibidor de la 5 -alfa- reductasa. Mediante las composiciones descritas se evita el trasplante capilar.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201430596A ES2549189B2 (es) | 2014-04-22 | 2014-04-22 | Composición para el tratamiento de la alopecia masculina |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201430596A ES2549189B2 (es) | 2014-04-22 | 2014-04-22 | Composición para el tratamiento de la alopecia masculina |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2549189A1 ES2549189A1 (es) | 2015-10-23 |
ES2549189B2 true ES2549189B2 (es) | 2016-09-15 |
Family
ID=54325826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201430596A Expired - Fee Related ES2549189B2 (es) | 2014-04-22 | 2014-04-22 | Composición para el tratamiento de la alopecia masculina |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2549189B2 (es) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19509354A1 (de) * | 1994-12-08 | 1996-06-13 | Klett Loch Lore M | Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall |
GB9706318D0 (en) * | 1997-03-26 | 1997-05-14 | Bryant Andrew E | Therapeutic formulations |
US7452527B2 (en) * | 2003-03-28 | 2008-11-18 | Murad, Inc. | Methods of promoting hair growth |
MXPA06009979A (es) * | 2004-03-02 | 2007-03-01 | Giuliani Spa | Composicion para regular el trofismo de foliculos pilosos y la produccion cutanea de sebo y el uso del mismo en alopecia androgenica. |
CN102698273A (zh) * | 2004-12-24 | 2012-10-03 | 都菲斯特股份有限公司 | 毛发学制剂和毛发学治疗 |
GB2461021A (en) * | 2008-06-10 | 2009-12-23 | Ajit Lalvani | Composition for the treatment of hair loss and baldness |
US20110256239A1 (en) * | 2010-04-15 | 2011-10-20 | Shapiro Lawrence J | Ingestible hair and finger nail growth promoter and method |
-
2014
- 2014-04-22 ES ES201430596A patent/ES2549189B2/es not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2549189A1 (es) | 2015-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017011535A2 (es) | Composiciones de ácido obeticólico y métodos de uso | |
CL2018001230A1 (es) | Tratamiento de osteoartritis | |
DOP2017000151A (es) | Derivados de quinazolina utilizados para tratar el vih | |
ECSP17070706A (es) | Inhibidores de bromodominio | |
SV2018005775A (es) | Forma polimorfa de n-{6-(2-hidroxipropan-2-il)-2-[2-(metilsulfonil)etil]-2h-indazol-5-il}-6-(trifluorometil)piridin-2- carboxamida | |
CO2017001884A2 (es) | Polimorfos de selinexor | |
SV2018005621A (es) | Inhibidor de la isocitrato deshidrogenasa mutada idh1 r132h | |
DOP2016000109A (es) | Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas. | |
CU20190101A7 (es) | Imidazopirimidinas diazabicíclicas sustituidas | |
CL2017000715A1 (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo | |
CL2016002338A1 (es) | Uso de un compuesto que es ácido r-2-4-2-etoxi-3-4-trifluorometilfenoxipropil-tio-2-metilfenoxi acético, para el tratamiento de una enfermedad colestásica intrahepática . | |
UY36920A (es) | Formulaciones de aminoácidos de liberación modificada administradas por vía oral | |
BR112017000730A2 (pt) | derivados de pirrolidinona como inibidores de metap-2 | |
UY36221A (es) | Derivados de isoindolinona | |
CR20160448A (es) | Nuevos derivados de piridina | |
BR112017025427A2 (pt) | composição farmacêutica oral | |
EA201790275A1 (ru) | Кристаллические формы 6-((6,7-диметоксихиназолин-4-ил)окси)-n,2-диметилбензофуран-3-карбоксамида | |
CL2018001493A1 (es) | Nuevos derivados de fenilo | |
BR112017007860A2 (pt) | método para tratar uma doença de gordura no fígado | |
CY1123877T1 (el) | Μορφες στερεας καταστασης αλατων νιλοτινιμπης | |
CL2018002149A1 (es) | Proceso. | |
DK3402573T3 (da) | Aminosyreholdig sammensætning | |
AR101951A1 (es) | Síntesis de ent-progesterona e intermediarios de la misma | |
BR112017012811A2 (pt) | novo tratamento para doenças hepáticas gordurosas não alcoólicas | |
ES2549189B2 (es) | Composición para el tratamiento de la alopecia masculina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 2549189 Country of ref document: ES Kind code of ref document: B2 Effective date: 20160915 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20220630 |